Objectives-Staphylococcus epidermidis is the predominant pathogen of deviceassociated infections. By forming biofilms on the device surface, S epidermidis has substantial resistance to antibiotics and is difficult to eradicate. This study aimed to explore the synergistic effect of ultrasound (US)-mediated microbubbles combined with vancomycin on S epidermidis biofilms in a rabbit model.
D
evice-associated infection is a serious concern in hospitalized patients, especially those with compromised immunity. The incidence of device-associated infection ranges from 6.2 to 10.8 per 1000 device days among different wards and can be up to 11.9 per 1000 device days in neonatal intensive care units. 1 Epidemiologic data show that coagulase-negative staphylococci, especially Staphylococcus epidermidis, have emerged as the predominant pathogens of device-associated infection. 2 Staphylococcus epidermidis ubiquitously colonize on the skin and can invade into the body via skinbreaching medical devices such as intravascular catheters, subcutaneous suture anchors, breast implants, and joint prostheses. 3 The key factor of S epidermidis pathogenesis is biofilm development. By definition, biofilms are sticky, surface-attached agglomerations of bacteria encased in self-produced extracellular polymeric substances. 4 Due to a general down-regulation of metabolic activities and the barrier function of the extracellular matrix, bacteria grown in biofilms have substantially increased resistance to antibiotics compared with their planktonic counterparts. 5, 6 Vancomycin is the choice of "last resort" for methicillin-resistant S epidermidis and other staphylococci. However, strains resistant to vancomycin are emerging, and the current vancomycin administration protocol may not be adequate to sustain an effective therapeutic range. 7 The recalcitrance of biofilms to antibiotic treatment has inspired other therapeutic alternatives. Lowfrequency ultrasound (US), defined as US waves of less than 1 MHz, is a promising physical method with advantages such as noninvasiveness, low cost, and minimal risk of inducing microbial resistance. [8] [9] [10] A series of studies demonstrated that low-frequency US combined with conventional antibiotics may kill more bacteria than antibiotics used alone. [11] [12] [13] [14] [15] [16] Ultrasonic enhancement of bactericidal action on biofilms was termed a "bioacoustic effect," the major mechanism of which was speculated to be sonoporation induced by US cavitation. 12, 14 Recently, microbubbles were shown to decrease the threshold for sonoporation by acting as the nuclei for cavitation. 9, 17 Microbubbles are gas-filled particles with sizes ranging from 1 to 8 lm. 9 With the application of US, microbubbles can oscillate or even collapse, resulting in a substantial bioeffect within minutes, an evidently shorter time than that achieved by US alone (2-48 hours). 9, 11, 12, 17 Literature shows that the application areas of microbubbles extend far beyond cardiovascular contrast imaging, and any acoustically accessible body parts or medical devices can become potential targets of USmediated microbubbles. 18 So far, there is a scarcity of studies regarding the combined effect of US with microbubbles and antibiotics on device-associated biofilm infections. Our previous in vitro experiment showed that US-mediated microbubbles could act synergistically with vancomycin against S epidermidis biofilms, and the effect was more pronounced than that of US 1 vancomcyin. 19 This study was a continuum of the previous study and aimed to investigate the effect of US-mediated microbubbles combined with systemic vancomycin on S epidermidis biofilms in an in vivo rabbit model. A thorough exploration of the bioeffects of US-mediated microbubbles may help expand our armamentarium of antibiofilm strategies.
Materials and Methods
Strain, Antibiotic, and Microbubbles Staphylococcus epidermidis (ATCC 35984 [RP62A]; American Type Culture Collection, Manassas, VA) was streaked out on tryptic soy agar (Oxoid, Cambridge, England) from frozen stocks. A single colony was inoculated into 5 mL of tryptic soy broth (Oxoid) and allowed to grow overnight at 378C with agitation (180 rpm). Bacteria were harvested and resuspended in tryptic soy broth to a turbidity of 0.5 McFarland standard. Vancomycin (Vancocin; Eli Lilly, Kobe, Japan) was reconstituted in distilled water and filter sterilized. Microbubbles were prepared according to an established protocol. 20, 21 Five milligrams of 1,2-distearoyl-sn-glycero-phosphatidylcholine (Sigma-Aldrich, St Louis, MO) and 2 mg of 1,2-dipalmi-toyl-sn-glycerol-3-phosphor-ethanolamine (Sigma-Aldrich) were mixed with 0.5 mL of 10% glycerol in a 1.5-mL vial. Then the vials were incubated at 458C until the chemicals were completely dissolved. After being filled with perfluoropropane gas, vials were vigorously shaken for 60 seconds in a dental amalgamator (YJT; Shanghai Medical Apparatuses and Instruments, Shanghai, China). Finally, the microbubble solution was diluted with 0.5 mL of phosphate-buffered saline and sterilized by 608C irradiation. The diameters of the prepared microbubbles were 4 to 6 lm, with a density of approximately 1.2 3 10 9 /mL. The microbubble solution was further diluted to a final concentration of 1% (vol/vol) in in vivo experiments.
In Vivo Rabbit Model A total of 16 New Zealand White rabbits weighing 2.3 to 2.5 kg were used in this study. All animals were maintained under the regulations of the Institutional Animal Care and Use Committee of Chongqing Medical University, and the in vivo experiment protocol was approved by the committee. Before surgery, polytetrafluoroethene single-lumen catheters of 1.6 3 2.0 mm in diameter were cut into 2-cm segments and autoclaved. Subsequently, sterile catheters were immersed in the S epidermidis bacterial solution, which was prepared as aforementioned, and incubated at 378C for 24 hours. Biofilm formation on the external surface of catheters was confirmed by scanning electron microscopy as described later. Rabbits were anesthetized with 10% chloral hydrate administered peritoneally (3 mL/kg). After the back of the rabbit was denuded of fur, biofilminfected catheters were implanted, as in previous studies. 11, 16 Briefly, 2 contralateral incisions were made perpendicular to the spine, and implant sites were created with blunt scissors to tunnel just beneath the skin. Two catheters with established biofilms were gently inserted into the subcutaneous tunnels, one on either side of the back, with a distance of at least 5 cm ( Figure 1 ). Then both of the incision sites were sutured. The rabbits were randomly divided into 4 treatment groups, with each animal serving as its own control and treatment: (1) control and US alone; (2) control and US 1 microbubbles; (3) vancomycin and vancomycin 1 US; and (4) vancomycin and vancomycin 1 US 1 microbubbles. This self-control design has been applied by previous studies. 11, 16, 22 Vancomycin (25 mg/kg) was administered through a marginal vein in one of the rabbits' ears immediately after surgery and 2 times a day thereafter. Ultrasound exposure commenced 24 hours after surgery. A US transducer with a surface area of 3.72 cm 2 was closely fixed on the skin over one of the tunneled catheters with acoustic coupling gels, and US energy was initiated immediately after the administration of vancomycin 2 times a day. A gene transfer machine (UGT 1025; Institute of Ultrasound Imaging, Chongqing Medical University, Chongqing, China) was used for experiments. The acoustic energy was applied for 5 minutes each time, at 300 kHz and 0.5 W/cm 2 in a 50% duty cycle as in the previous study. 19 Biofilms in the control group received sham US exposure with the US apparatus turned off. For animals receiving US combined with microbubbles, a total volume of 0.5 mL of the microbubble solution was injected subcutaneously into the area of the implanted catheters just before the application of US. After treatment with US for 48 hours, the rabbits were maintained for another 12 hours and then euthanized. The implanted catheters were removed with sterile forceps. Biofilms on catheters were rinsed with phosphatebuffered saline and subjected to plate counting and scanning electron microscopy.
Blood was sampled from a marginal vein in the opposite ear before surgery and every 24 hours thereafter just before the administration of vancomycin. The Figure 1 . Schematic illustration of subcutaneous implant-associated biofilm infection in a rabbit model. Two catheters with established biofilms were inserted contralaterally via subcutaneous tunnels on either side of the rabbit's back. The rabbit serves as its own control and treatment. Ultrasound or US combined with microbubbles was administered to the biofilm-infected catheter on one side of the back (treatment), and the catheter on the other side was the control. A microbubble solution (0.5 mL) was injected subcutaneously into the implantation site where US was applied. In groups receiving vancomycin, the antibiotic was administered through a marginal vein in one of the rabbit's ears.
last sample was taken before euthanasia. The sampled blood was diluted and plated onto tryptic soy agar to determine whether bacteria disseminated into the bloodstream. In addition, the hearts, livers, kidneys, and subcutaneous tissues at the insonated site were collected for independent histopathologic examinations.
Biofilm Evaluation
Each catheter was cut longitudinally into 2 equal segments with a sterile scalpel. One segment was rinsed with phosphate-buffered saline and subsequently dispersed in tryptic soy broth by sonication at 20 kHz for 5 seconds (UD-201; Tomy, Tokyo, Japan) at room temperature. This procedure has been not to affect bacterial culturability by our preliminary results. Bacteria were harvested and enumerated by serial dilutions and plating techniques using tryptic soy agar, with bacterial counts expressed as log 10 colony-forming units per catheter. The other segment was fixed for 2 hours at 48C with 2% glutaraldehyde and rinsed twice in phosphate-buffered saline. Dehydration was performed in progressively increasing concentrations of ethanol from 30% to 100%. After being lyophilized, each sample was coated with gold by a gold sputter and observed with an S-3000 scanning electron microscope (Hitachi HighTechnologies, Tokyo, Japan).
Statistical Analyses
Data were expressed as mean 6 standard deviation. The Student t test and 1-way analysis of variance were used for independent unpaired data and multigroup comparisons, respectively. Error bars shown in the figures are standard deviations. Statistical analyses were performed with SPSS version 17.0 software (IBM Corporation, Armonk, NY). P < .05 was considered statistically significant.
Results

Biofilm Viability in the In Vivo Experiment
Before implantation, the biofilms contained 7.28 6 0.03 log 10 colony-forming units per catheter. After 72 hours, the rabbit's own immune system (without insonation and systemic antibiotic) reduced the biofilm viability by approximately 1 order of magnitude (P < .001). The application of US or US 1 microbubbles did not exert a bactericidal effect on S epidermidis biofilms compared with the control (P 5 .911 and .572, respectively). As shown in Figure 2 , systemic administration of vancomycin reduced bacterial counts to 5.39 6 0.04 log 10 colony-forming units per catheter, and US enhanced the bactericidal action of vancomycin by further decreasing biofilm viability to 5.15 6 0.03 log 10 colony-forming units per catheter (P 5 .01). The treatment with US 1 microbubbles 1 vancomycin had the most significant antibacterial effect among all groups (P < .001), showing log 10 reductions of 1.66 and 2.94 compared with US 1 vancomycin and the control, respectively.
Scanning Electron Microscopic Examination of Biofilms In Vivo
A dense and compact biofilm was formed on the catheter before implantation (Figure 3 ). Treatment with US or US 1 microbubbles did not change the density and structure of the biofilm compared with the control. After vancomycin treatment, the biofilm mass was reduced, leaving bacterial clusters. The biofilm-eradicating effect was more pronounced with US 1 vancomycin treatment. Biofilms exposed to US 1 microbubbles 1 vancomycin showed the greatest reduction in thickness and bacterial density, with bacteria sparsely scattered on the surface of catheters.
Blood Sample and Histopathologic Results
None of the collected blood samples showed S epidermidis bacteremia. A fibrous capsule was formed around the implanted catheters at the time when the catheters were taken out. As shown in Figure 4 , no signs of vessel rupture or skin necrosis due to the intervention of US or US 1 microbubbles were observed. The peri-implant tissue in the control group contained large numbers of infiltrated neutrophils. Changes in the inflammatory reaction under different treatment conditions showed a similar pattern as those in biofilm viability and scanning electron microscopy. The treatment with US 1 microbubbles 1 vancomycin showed a more significant reduction in the inflammatory response than the other interventions. Histopathologic examinations did not detect abnormalities in the hearts, livers, and kidneys of the rabbits.
Discussion
The use of US-mediated microbubbles is evolving as a novel method for treating device-associated biofilm infections in a noninvasive and effective manner. Although limited, current data show that US combined with microbubbles may substantially enhance the activity of antimicrobial substances against biofilms, and the effect might be much greater than that achieved by US alone. 19, 23, 24 Noteworthily, these data are largely derived from in vitro experiments. To facilitate the transition of this technology from research laboratories to clinical use, animal studies are desperately needed to investigate the effect of US-mediated microbubbles with antibiotics on biofilms and the surrounding tissue in vivo. Consistent with a previous study, 23 our results demonstrated that the synergistic action of US-mediated microbubbles and antibiotics also existed in vivo, and the animal's immune system may further assist the reduction of the bacterial count by 1 order of magnitude. Despite the low US energy used in this study (300 kHz and 0.5 W/cm 2 in a 50% duty cycle for a total of 20 minutes), our results demonstrated that the reduction of bacterial counts with US 1 microbubble 1 vancomycin treatment was approximately 3 orders of magnitude compared with the control. As the minimal biofilm eliminating concentration for an antimicrobial substance is often achieved when 99.9% of biofilm-grown bacteria are killed, 25, 26 which corresponds to a 3 log 10 reduction in viability, our results indicated a substantial treatment effect in that US 1 microbubbles significantly enhanced the susceptibility of biofilms to vancomycin. Extending the duration of treatment may further reduce the number of viable bacteria in biofilms. However, previous studies investigating the combined effect of US and antibiotics on animal biofilm infection models showed no further changes in biofilm viability beyond 72 hours of treatment, 11, 16 suggesting that a plateau may exist for this kind of treatment strategy. Furthermore, prolonged treatment may increase the risk of tissue damage, as will be discussed below.
Our study showed that the intervention of US alone or US 1 microbubbles did not do any damage to the skin and organs while exerting an effective antibacterial action, indicating that these technologies may be well tolerated by the body and have the potential to be safely applied. The rationale behind this idea is that bacteria and eukaryotic cells have different susceptibilities to US energy. Possible explanations mainly include the following: (1) in contrast to bacteria, which have rigid cell walls, eukaryotic cells are composed of flexible phospholipid bilayers that may well absorb US energies and prevent cells from shattering 10 ; (2) eukaryotic cells are Figure 2 . Recovery of bacteria from in vivo biofilms treated under different conditions. Asterisks denote statistically significant differences from preimplantation (P <.05); triangles denote statistically significant differences from the control (P <.05); circles denote statistically significant differences from the vancomycin-alone treatment (P <.05); squares denote statistically significant differences from the US 1 vancomycin treatment (P <.05). MB indicates microbubbles. ; and (3) bacteria may respond to the peak US intensity and not to the total amount of energy delivered, as seen in eukaryotic cells. 27 Therefore, it is possible to find a safety window of operation in which one can use US energy at a sufficiently high peak intensity to enhance the antibacterial action while still maintaining the average intensity at a safe level that does not injure the surrounding eukaryotic cells. 27 Furthermore, the concentration of microbubbles is an important factor to consider in the application of US, as a bubble dose-dependent bioeffect has been observed previously. 19 The underlying mechanisms of bioacoustic effects are multifaceted. Sonoporation induced by US cavitation is considered to be the most important mechanism. [11] [12] [13] [14] [15] [16] Cavitation is characterized by the formation and radial oscillation of microbubbles in the acoustic field.
14 In stable cavitation, the oscillation of microbubbles is sustained in a small amplitude. 14 The shear stress and microstreaming generated by stable cavitation may create transient pores on cell membranes, a process termed sonoporation, increasing cellular permeability to extracellular substances while keeping cells alive.
14 In contrast, inertial cavitation is characterized by the collapse of microbubbles, or US targeted microbubble destruction, which is capable of producing high-energy microjets and may result in a more pronounced sonoporation effect than stable cavitation. 28 As a result, cell death may ensue. 14, 28 The activity of microbubbles is dependent on a series of factors, such as bubble size, frequency, and acoustic pressure amplitudes. 29 Adding exogenous microbubbles to the acoustic field may facilitate the process of inertial cavitation. 28 Previous studies showed that the targets of US sonoporation may not be limited to bacterial membranes and may also include the extracellular matrix. 19, 30 Sonoporation may facilitate the flux of nutrients as well as antibiotics through a biofilm, disrupting the heterogeneity of biofilm-embedded bacteria and restoring bacterial susceptibility to antibiotics. 30, 31 The different antibacterial effects observed between the US 1 vancomycin treatment and the US 1 microbubble 1 vancomycin treatment may be explained by the difference between stable cavitation and inertial cavitation. Apart from physical mechanisms, biochemical mechanisms may also underlie bioacoustic effects. Data from in vitro studies indicated that US and US-mediated microbubbles could alter the expression patterns of genes involved in virulence, polysaccharide synthesis, and the quorum sensing system of biofilms. 24, 32 Furthermore, reactive oxygen species produced in the process of cavitation may also be implicated in the US enhancement of the antibiotic action, although their role may be subsidiary. 33 Strengths of our study included the successful establishment of a rabbit model of subcutaneous implantassociated biofilm infection and the exploration of a microbubble-based treatment regimen. We attempted to make our experiment closer to the scenarios in clinical practice by tailoring the administration of vancomycin to current treatment protocols. In the future, more studies are warranted to fully explore the effect of US microbubbles against biofilms. Research on the synergistic bactericidal action of US-targeted microbubbles is still in its infancy. Multiple factors, such as the US frequency, intensity, duty cycle, duration of treatment, as well as microbubble concentration, may affect the US-enhanced antimicrobial activity against biofilms. 23, 34, 35 In addition, biofilms of various ages and bacterial species may respond differently to US energy. 11, 30, 35 To obtain an optimal bactericidal effect against biofilms encountered in clinical practice, a myriad of US parameter combinations need to be thoroughly evaluated. Furthermore, the safety of US combined with microbubbles remains a great concern in clinical applications, and more in vivo studies are needed to identify the window for effective and safe operation. There is accumulating evidence that US may have an impact on host immune cell responses, thereby promoting the healing of infected wounds. 36, 37 Our study revealed signs of attenuated inflammatory reactions after the US or US 1 microbubble intervention. This finding provides an interesting area of research, which may corroborate the role of US technology in treating biofilm-associated infections if positive results are obtained.
Taken together, US-mediated microbubbles may increase the antibacterial activity of vancomycin against S epidermidis biofilms in vivo without doing harm to the skin and organs. This technology holds promise to provide an effective and noninvasive method for treating device-related biofilm infections.
